UNSPSC 51453403: Santonin

This classification denotes an antihelminthic agent with the molecular formula C15H18O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1VL8J38ERO, chemically known as 11-epiisoeusantona-1,4-dienic acid, 6alpha-hydroxy-3-oxo-, gamma-lactone but generally known as alpha-santonin, which bears US NIH Compound Identifier 10201. European Medicines Agency schedules Santonin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15192MIG.

As of Q4 2014, SANTONIN remains the US FDA Preferred Term for this commodity. Santonin bears US NLM identifiers UMLS ID C0036179 and NCI Concept Code C87627. SMILES: CC1C2CCC3(C=CC(=O)C(=C3C2OC1=O)C)C.

UNSPSC 51453403 Santonin, a Commodity code, nominally addresses a specific pharmaceutical active ingredient, but recent state and local procurement activity under this code reflects a broader pharmaceutical supply and acquisition landscape. State and local governments use this code to procure pharmaceutical products through cooperative purchasing arrangements and direct competitive bidding. The Illinois Department of Public Health and Seminole County, Florida represent the issuing-body mix, with both purchasing pharmaceutical products—one through a multi-state cooperative purchasing consortium and the other through independent county procurement. The scope of work encompasses both scheduled pharmaceutical inventory (antibiotics and antimalarials sourced through piggyback contracts) and emergency response medications (naloxone and drug deactivation systems for community health initiatives).

Recent activity concentrates in Illinois and Florida. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse order through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, for Doxycycline Hyclate and Ciprofloxacin Hydrochloride with a total award value of $2,999,999.11 over a three-year contract term including renewal options; this was completed through an Invitation for Bid process. Seminole County, Florida issued an IFB (IFB60459723LAS) on June 30, 2026, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the county's Community Health Building in Sanford, Florida, with bidders required to submit electronically and include all shipping and delivery costs; the response deadline was July 26, 2026. Both opportunities reflect state and local reliance on fixed-fee, quantity-based pharmaceutical procurement with multi-year contract terms and delivery compliance requirements.